Double maintains 1 strategies that include RVMD - Revolution Medicines, Inc.
Yahoo
The trial will assess the efficacy and safety of the therapy against docetaxel chemotherapy.
Yahoo
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been dosed in RASolve 301, a global, randomized, open-label Phase 3 clinical trial. RASolve 301 will evaluate the safety and efficacy of daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor, in patients with previously treated, locally advanced or
Yahoo
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Yahoo
Q1 2025 Revolution Medicines Inc Earnings Call
Yahoo
Revolution Medicines Inc (RVMD) reports significant progress in RAS(ON) inhibitors and a strong financial position, despite increased R&D and net losses.
Yahoo
Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this yearNew non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio support strategies for first-line metastatic and earlier lines of treatmentAnthony Mancini joins as chief global commercialization officerRevolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., May 07, 2025 (GL
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 66.24% | $4.85B | 0.35% |
GNOM | 61.36% | $40.65M | 0.5% |
IBB | 59.17% | $5.22B | 0.45% |
PTH | 55.99% | $96.56M | 0.6% |
IWO | 55.91% | $11.36B | 0.24% |
ARKG | 55.91% | $944.78M | 0.75% |
PBE | 55.89% | $214.12M | 0.58% |
ISCG | 54.67% | $645.00M | 0.06% |
VTWO | 53.78% | $12.07B | 0.07% |
IWC | 53.66% | $766.88M | 0.6% |
KJUL | 53.57% | $113.35M | 0.79% |
IWM | 53.50% | $63.95B | 0.19% |
SCHA | 53.41% | $16.91B | 0.04% |
XPH | 53.29% | $136.58M | 0.35% |
KJAN | 53.10% | $305.13M | 0.79% |
TMSL | 52.73% | $748.48M | 0.55% |
VBK | 52.66% | $18.33B | 0.07% |
ESML | 52.36% | $1.81B | 0.17% |
VXF | 52.33% | $21.56B | 0.05% |
NUSC | 52.01% | $1.14B | 0.31% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.71% | $22.95B | +20.67% | 1.12% |
LITB | -11.89% | $21.28M | -72.45% | 0.00% |
CME | -8.30% | $98.74B | +28.80% | 3.84% |
PSQH | -7.81% | $89.26M | -49.87% | 0.00% |
ED | -7.66% | $36.75B | +5.26% | 3.28% |
FMTO | -6.20% | $45.74M | -99.96% | 0.00% |
COR | -6.08% | $55.43B | +28.90% | 0.56% |
K | -5.64% | $28.49B | +32.17% | 2.77% |
MKTX | -5.44% | $8.01B | -1.42% | 1.39% |
HEES | -4.56% | $3.52B | +99.54% | 1.15% |
LTM | -4.51% | $11.01B | -96.75% | 2.75% |
AQB | -4.24% | $2.96M | -61.58% | 0.00% |
CODI | -4.13% | $580.07M | -65.16% | 12.97% |
AWK | -3.98% | $27.37B | +4.54% | 2.22% |
EXC | -3.01% | $43.84B | +12.45% | 3.59% |
VSA | -2.82% | $7.04M | -49.24% | 0.00% |
KO | -2.57% | $308.23B | +13.09% | 2.75% |
OXBR | -2.50% | $14.89M | +14.29% | 0.00% |
AIFU | -2.39% | $9.85M | -95.03% | 0.00% |
VHC | -2.30% | $34.69M | +74.89% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -43.28% | $140.49M | 0.59% |
VIXY | -39.82% | $109.64M | 0.85% |
BTAL | -35.04% | $361.41M | 1.43% |
FTSD | -21.13% | $212.46M | 0.25% |
IVOL | -18.69% | $353.94M | 1.02% |
SHYM | -18.14% | $322.93M | 0.35% |
ULST | -17.70% | $637.77M | 0.2% |
FXY | -17.18% | $838.61M | 0.4% |
XONE | -15.75% | $603.24M | 0.03% |
SPTS | -15.71% | $5.76B | 0.03% |
BSMW | -15.36% | $102.62M | 0.18% |
TPMN | -14.86% | $31.54M | 0.65% |
SCHO | -13.55% | $10.87B | 0.03% |
UTWO | -12.66% | $387.71M | 0.15% |
XHLF | -12.23% | $1.46B | 0.03% |
VGSH | -11.91% | $22.38B | 0.03% |
IBTH | -11.16% | $1.53B | 0.07% |
DFNM | -10.73% | $1.53B | 0.17% |
LDUR | -10.58% | $849.09M | 0.5% |
CGSM | -10.54% | $658.61M | 0.25% |
Current Value
$39.371 Year Return
Current Value
$39.371 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SCHQ | <0.01% | $829.57M | 0.03% |
SCHP | 0.02% | $12.81B | 0.03% |
UITB | 0.04% | $2.42B | 0.39% |
SHAG | 0.06% | $37.97M | 0.12% |
HTRB | 0.08% | $1.95B | 0.29% |
VGLT | -0.09% | $9.57B | 0.04% |
PULS | 0.09% | $11.17B | 0.15% |
CARY | -0.09% | $347.36M | 0.8% |
VTEB | -0.20% | $35.64B | 0.03% |
IAGG | -0.21% | $7.30B | 0.07% |
BIV | -0.24% | $22.85B | 0.03% |
TOTL | 0.26% | $3.59B | 0.55% |
IBMP | 0.26% | $531.75M | 0.18% |
JMBS | -0.31% | $5.40B | 0.22% |
SPTL | -0.34% | $10.96B | 0.03% |
CGMU | 0.39% | $3.10B | 0.27% |
CANE | 0.41% | $10.71M | 0.29% |
TLH | -0.46% | $9.85B | 0.15% |
HYMB | -0.54% | $2.53B | 0.35% |
OWNS | -0.66% | $134.57M | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 58.21% | $1.95B | -15.67% | 0.00% |
CRNX | 54.86% | $2.92B | -39.88% | 0.00% |
IDYA | 53.49% | $1.52B | -58.32% | 0.00% |
DYN | 50.26% | $1.33B | -59.17% | 0.00% |
RARE | 50.17% | $3.29B | -18.24% | 0.00% |
DNLI | 50.13% | $2.06B | -30.04% | 0.00% |
DAWN | 49.23% | $624.39M | -61.57% | 0.00% |
XENE | 49.18% | $2.27B | -26.70% | 0.00% |
CLDX | 48.77% | $1.33B | -49.67% | 0.00% |
ACLX | 48.74% | $3.22B | +10.72% | 0.00% |
BEAM | 48.73% | $1.73B | -27.49% | 0.00% |
JHG | 48.66% | $6.05B | +12.18% | 4.08% |
RCKT | 48.37% | $724.54M | -71.26% | 0.00% |
IMNM | 48.03% | $696.10M | -44.44% | 0.00% |
NRIX | 47.94% | $721.19M | -38.57% | 0.00% |
KRYS | 47.63% | $3.77B | -20.42% | 0.00% |
NTLA | 47.19% | $836.43M | -69.14% | 0.00% |
OCUL | 47.04% | $1.14B | +14.35% | 0.00% |
VYX | 47.02% | $1.50B | -18.43% | 0.00% |
BHVN | 46.83% | $1.62B | -58.86% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VZ | 0.01% | $183.32B | +8.02% | 6.21% |
DOGZ | -0.14% | $231.95M | +120.05% | 0.00% |
AEP | 0.20% | $54.28B | +9.80% | 3.61% |
T | 0.24% | $196.66B | +57.98% | 4.07% |
DG | 0.26% | $20.45B | -36.56% | 2.55% |
SYPR | -0.38% | $37.69M | +21.48% | 0.00% |
CMS | -0.39% | $21.21B | +12.27% | 2.97% |
GFI | -0.47% | $18.61B | +31.67% | 2.75% |
CYCN | -0.64% | $9.37M | +2.39% | 0.00% |
HSY | 0.64% | $33.16B | -21.37% | 3.44% |
BGS | -0.65% | $355.90M | -53.30% | 17.00% |
CHD | 0.72% | $23.29B | -11.36% | 1.23% |
TU | 0.74% | $23.77B | -4.62% | 7.19% |
VSTA | 0.75% | $326.82M | +11.64% | 0.00% |
NEUE | 0.93% | $62.05M | +13.56% | 0.00% |
MOH | -0.97% | $17.02B | -8.99% | 0.00% |
STG | 1.15% | $27.05M | -37.35% | 0.00% |
TAP | 1.16% | $11.38B | -2.05% | 3.16% |
CL | -1.17% | $72.64B | -5.18% | 2.25% |
CCRN | 1.20% | $457.33M | -5.30% | 0.00% |